The fintech firm raised its full-year outlook after exceeding Q2 guidance for the second straight quarter.
Paysign Inc. (PAYS) increased its 2026 revenue forecast to a range of $114M-$117M, citing strong demand for patient affordability programs. The company now expects 165-170 active programs in Q3, up from prior projections.
Q2 2026 results set new records for revenue, net income, and adjusted EBITDA, marking the second consecutive quarter of surpassing quarterly guidance. Management attributed the performance to expanding program adoption and operational efficiency.
The updated outlook reflects confidence in sustained growth amid rising healthcare affordability challenges.